Pfizer Inc

NYSE: PFE
$29.36
-$0.06 (-0.2%)
Real Time Data Delayed 15 Min.

PFE Articles

ThinkstockApril 1, 2016: Markets opened lower on Friday following the monthly employment report from the Bureau of Labor Statistics. The unemployment rate ticked up to 5% and job growth was slightly...
March 31, 2016: Markets opened higher again on Thursday but only the Nasdaq Composite was able to hold on for a modest gain on the day. The only sector to trade higher for the day was utilities and...
Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the sentiment may be less than stellar now, massive drug pricing changes...
Interest in almost all of the most heavily shorted stocks traded on the New York Stock Exchange shrank between the February 29 and March 15 settlement dates. Except for Pfizer, that is.
March 21, 2016: Markets opened lower on Monday on some weakness overnight in oil prices. The morning report on existing home sales weighed on equity prices as well. A number of merger announcements...
Pfizer announced the results from its first two pivotal Phase 3 studies from the Oral Clinical Trials for tofacitinib in ulcerative colitis program at the 11th Congress of European Crohn's and...
So what are investors to do in a continued low rate environment? Buy the best stocks out there, especially ones paying good dividends.
One analyst firm believes the development of abuse-deterrent formulations (ADF) of opioids creates a risk that older non-ADFs may be removed from the market, creating a huge risk and opportunity in...
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
March 11, 2016: Markets opened higher again on Friday and held on to the early gains all day. Energy and financials stocks led the gainers and only 2 of 10 sectors posted losses: consumer staples and...
24/7 Wall St. screened the Merrill Lynch research data base for solid growth ideas that also paid a dividend of at least 4%.
The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest decreased.
Most of the stocks traded on the New York Stock Exchange with the greatest number of shares short saw their short interest decline between the February 12 and February 29 settlement dates.
The top analyst upgrades, downgrades and initiations seen on Tuesday, March 8, include AutoNation, Celldex Therapeutics, EP Energy, Shopify, Sony, Urban Outfitters and Valeant Pharmaceuticals.
So far this year, based on changes in yields, the Dogs of the Dow are doing much better, as their yields have not widened out near as much as the other 20 Dow companies.